Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (โOSAโ) and snoring in adults, will be presenting at todayโs Emerging Growth Conference. The company announced that chair and CEO Kirk Huntsman will be participating in the conference; Huntsmanโs presentation is scheduled to begin at 12:35 p.m. ET; anyone interested can register and view the presentation. The company is inviting institutional and individual investors, advisors and analysts, to attend the interactive presentation.ย The presentation will also be available on the company website following the conference.
To view the presentation, visitย https://ibn.fm/9jHeo
To view the full press release, visitย https://ibn.fm/FEFbF
About Vivos Therapeutics Inc.
Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (โOSAโ) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of approximately than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (โCAREโ) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patientโs upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (โVIPโ) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visitย www.VivosLife.com. ย
NOTE TO INVESTORS:ย The latest news and updates relating to VVOS are available in the companyโs newsroom atย http://ibn.fm/VVOS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products youโll need to ensure that your next press release grabs the attention of your target audience and doesnโt let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWireโs syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visitย https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:ย http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of theย InvestorBrandNetwork
